Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,537
+$317 QoQ
Shares Held
80
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,525
of 1,603 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nemes Rush Group LLC holds $73,842,544 across 14 Drug Manufacturers - General names. NVS ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
91,397 | $23,212,096 | |
| 2 | MRK |
Merck & Co., Inc.
|
175,548 | $22,557,918 | |
| 3 | LLY |
ELI LILLY & Co
|
15,575 | $18,681,123 | |
| 4 | ABBV |
AbbVie Inc.
|
15,922 | $4,006,612 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
26,864 | $3,393,997 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 7 | PFE |
Pfizer Inc
|
12,129 | $292,066 | |
| 8 | AMGN |
Amgen Inc
|
155 | $56,128 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,537 | 80 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,220 | 80 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $11,029 | 80 | Shares | Sole | 2026-02-11 | |
| 2024-03-31 | $45,076 | 466 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $47,052 | 466 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $47,466 | 466 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $47,024 | 466 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||